Crescent Biopharma (CBIO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec4

CoLon Biotech and Crescent Biopharma Enter into Collaboration for Oncology Drug Development

11:48

Crescent Biopharma and Kelun-Biotech Partner to Develop Novel Cancer Treatments

11:30

Nov10

H.C. Wainwright Reiterates Buy Rating on Crescent Biopharma

11:56

Nov7

Crescent Biopharma released FY2025 9 Months Earnings on November 6, 2025 EST, with actual revenue USD 0 and EPS USD -24.5846

04:00

Crescent Biopharma released FY2025 Q3 earnings on November 6, 2025, EST: Actual Revenue USD 0 (Forecast USD 0), Actual EPS USD -1.2663 (Forecast USD -1.352)

04:00

Nov6

LifeSci Capital Analyst Maintains Buy Rating on Crescent Biopharma

20:26

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -24.61 M, EPS -1.2663

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.79 M, EPS -4.9272

Jun16

Reverse Stock Split(EST)

1-for-100 Reverse Stock Split

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change